Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Early Phase 1

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Early Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06270680Early Phase 1Completed

Carotenoids for Collision Athletes

Role: collaborator

NCT03779269Not ApplicableUnknown

Effect of Preksha Meditation on Cognitive Abilities and Pulmonary Function in Students

Role: lead

NCT02284178Not ApplicableCompleted

Oral Suction Intervention to Reduce Aspiration and Ventilator Events: NO-ASPIRATE

Role: collaborator

NCT03398746Not ApplicableCompleted

The LOOP Trial in Treatment of Skin Abscesses

Role: lead

NCT01230255Phase 3Completed

Percutaneous Catheter Decompression in the Treatment of Elevated Intra-abdominal Pressure

Role: lead

NCT00336427Completed

MRSA Colonization in Peripartum Women and Their Offspring

Role: lead

All 6 trials loaded